SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+8.18%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$235M
AUM Growth
+$235M
(+4.8%)
Cap. Flow
-$666K
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
51.02%
Holding
47
New
7
Increased
8
Reduced
13
Closed
11
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$29.6M |
| 2 |
Abbott
ABT
|
$6.84M |
| 3 |
Medtronic
MDT
|
$5.4M |
| 4 |
Revvity
RVTY
|
$5.11M |
| 5 |
Zimmer Biomet
ZBH
|
$4.32M |
Top Sells
| 1 |
Merck
MRK
|
$8.16M |
| 2 |
Thermo Fisher Scientific
TMO
|
$7.74M |
| 3 |
Biogen
BIIB
|
$6.96M |
| 4 |
ResMed
RMD
|
$5.74M |
| 5 |
Edwards Lifesciences
EW
|
$5.54M |
Sector Composition
| 1 | Healthcare | 87.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Smith & Nephew
SNN
$16.3B
| $4.36M | 1.85% |
140,000
-10,000
| -7% | -$311K |
|
|
27
Zimmer Biomet
ZBH
$21B
| $4.32M | 1.83% |
+40,000
| New | +$4.32M |
|
28
Repligen
RGEN
$6.88B
| $3.72M | 1.58% |
25,000
+10,000
| +67% | +$1.49M |
|
29
Maravai LifeSciences
MRVI
$350M
| $3.53M | 1.5% |
425,000
-25,000
| -6% | -$208K |
|
30
Humana
HUM
$36.5B
| $3.17M | 1.34% |
10,000
+2,500
| +33% | +$792K |
|
31
Teva Pharmaceuticals
TEVA
$21.1B
| $3.06M | 1.3% |
170,000
-30,000
| -15% | -$541K |
|
32
Stevanato
STVN
$6.28B
| $2.8M | 1.19% |
+140,000
| New | +$2.8M |
|
33
Ascendis Pharma
ASND
$11.8B
| $1.49M | 0.63% |
+10,000
| New | +$1.49M |
|
34
Agilent Technologies
A
$35.7B
| – | – |
-35,000
| Closed | -$4.54M |
|
|
35
Biogen
BIIB
$19.4B
| – | – |
-30,000
| Closed | -$6.96M |
|
36
Bruker
BRKR
$5.16B
| – | – |
-40,000
| Closed | -$2.55M |
|
37
DexCom
DXCM
$29.5B
| – | – |
-30,000
| Closed | -$3.4M |
|
|
38
Edwards Lifesciences
EW
$47.8B
| – | – |
-60,000
| Closed | -$5.54M |
|
39
Medpace
MEDP
$13.4B
| – | – |
-7,500
| Closed | -$3.09M |
|
|
40
Merck
MRK
$210B
| – | – |
-65,874
| Closed | -$8.16M |
|
41
Natera
NTRA
$23.1B
| – | – |
-30,000
| Closed | -$3.25M |
|
42
Insulet
PODD
$23.9B
| – | – |
-25,000
| Closed | -$5.05M |
|
|
43
ResMed
RMD
$40.2B
| – | – |
-30,000
| Closed | -$5.74M |
|
|
44
Thermo Fisher Scientific
TMO
$186B
| – | – |
-14,000
| Closed | -$7.74M |
|